English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/81944
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


The role of the NFκB signalling pathway in cancer

AuthorsCortés-Sempere, María; Rodriguez-Fanjul, V. ; Sánchez-Pérez, Isabel; Perona Abellón, Rosario
Issue Date2008
CitationClinical and Translational Oncology 10(3): 143-147 (2008)
AbstractThe nuclear factor kappa B (NFΚB) signalling pathway regulates the expression of hundreds of genes that are involved in different cellular processes such as cell proliferation, survival, stress responses, cellular immunity and inflammation. Its aberrant regulation is involved in several pathologies, but its relevance in cellular transformation and cancer development has been extensively studied. Mutations in the core components of NFΚB as well as in the cellular machinery that regulates its activation have been found in many types of tumours. On the other hand, its role in promoting cell survival is an important obstacle in many cancer therapies. The development of chemical inhibitors that block NFΚB activation acting either directly on IKKs or on the proteosome machinery has shown antitumour and proapoptotic activity both in preclinical and clinical studies. © Feseo 2008.
Identifiersdoi: 10.1007/s12094-008-0171-3
issn: 1699-048X
e-issn: 1699-3055
Appears in Collections:(IIBM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.